TrialCancer science2017
Personalized peptide vaccination as second-line treatment for metastatic upper tract urothelial carcinoma.
Shigetaka Suekane et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papertrialcites it